Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 13 studies | 30% ± 14% | |
| peripheral blood | 13 studies | 27% ± 8% | |
| kidney | 7 studies | 23% ± 4% | |
| intestine | 7 studies | 26% ± 11% | |
| brain | 7 studies | 26% ± 10% | |
| eye | 6 studies | 23% ± 10% | |
| liver | 5 studies | 25% ± 13% | |
| pancreas | 4 studies | 42% ± 15% | |
| placenta | 4 studies | 29% ± 9% | |
| bone marrow | 4 studies | 22% ± 6% | |
| uterus | 4 studies | 36% ± 14% | |
| prostate | 4 studies | 24% ± 8% | |
| lymph node | 4 studies | 29% ± 13% | |
| breast | 4 studies | 27% ± 3% | |
| adrenal gland | 3 studies | 22% ± 2% | |
| skin | 3 studies | 21% ± 3% | |
| thymus | 3 studies | 37% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 3297.65 | 258 / 258 | 100% | 89.01 | 230 / 230 |
| bladder | 100% | 3352.90 | 21 / 21 | 100% | 110.55 | 504 / 504 |
| esophagus | 100% | 3367.07 | 1445 / 1445 | 100% | 69.62 | 183 / 183 |
| liver | 100% | 1875.83 | 226 / 226 | 100% | 67.40 | 406 / 406 |
| ovary | 100% | 3311.07 | 180 / 180 | 100% | 105.26 | 430 / 430 |
| pancreas | 100% | 1855.14 | 328 / 328 | 100% | 67.70 | 178 / 178 |
| uterus | 100% | 3260.12 | 170 / 170 | 100% | 124.55 | 459 / 459 |
| brain | 100% | 3090.64 | 2640 / 2642 | 100% | 64.92 | 705 / 705 |
| thymus | 100% | 2836.55 | 653 / 653 | 100% | 57.80 | 604 / 605 |
| intestine | 100% | 3053.92 | 966 / 966 | 100% | 100.32 | 526 / 527 |
| stomach | 100% | 2262.82 | 359 / 359 | 100% | 92.29 | 285 / 286 |
| breast | 100% | 3209.91 | 459 / 459 | 100% | 79.99 | 1114 / 1118 |
| prostate | 100% | 2810.99 | 245 / 245 | 100% | 61.92 | 500 / 502 |
| lung | 99% | 3073.93 | 575 / 578 | 100% | 93.24 | 1154 / 1155 |
| kidney | 100% | 2648.70 | 89 / 89 | 99% | 59.16 | 893 / 901 |
| skin | 100% | 3287.03 | 1809 / 1809 | 98% | 66.01 | 463 / 472 |
| adipose | 100% | 3260.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 93.69 | 29 / 29 |
| muscle | 100% | 3398.07 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2440.30 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 95.28 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 62.27 | 1 / 1 |
| blood vessel | 100% | 3223.02 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 3258.21 | 855 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 89% | 34.37 | 71 / 80 |
| peripheral blood | 49% | 1409.24 | 456 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0090200 | Biological process | positive regulation of release of cytochrome c from mitochondria |
| GO_0006915 | Biological process | apoptotic process |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_1903645 | Biological process | negative regulation of chaperone-mediated protein folding |
| GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO_1903638 | Biological process | positive regulation of protein insertion into mitochondrial outer membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0010698 | Molecular function | acetyltransferase activator activity |
| GO_0003677 | Molecular function | DNA binding |
| GO_0008201 | Molecular function | heparin binding |
| GO_0048487 | Molecular function | beta-tubulin binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PDCD5 |
| Protein name | Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19) Programmed cell death 5 |
| Synonyms | TFAR19 |
| Description | FUNCTION: May function in the process of apoptosis. |
| Accessions | K7ESJ4 ENST00000221784.8 ENST00000586035.1 ENST00000592786.5 ENST00000379316.3 ENST00000590247.7 [O14737-1] X6R2P6 O14737 K7EQA1 ENST00000419343.7 [O14737-2] Q3HM38 |